These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 25820842)

  • 1. Serotonergic psychedelics temporarily modify information transfer in humans.
    Alonso JF; Romero S; Mañanas MÀ; Riba J
    Int J Neuropsychopharmacol; 2015 Mar; 18(8):. PubMed ID: 25820842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans.
    Valle M; Maqueda AE; Rabella M; Rodríguez-Pujadas A; Antonijoan RM; Romero S; Alonso JF; Mañanas MÀ; Barker S; Friedlander P; Feilding A; Riba J
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1161-75. PubMed ID: 27039035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the Psychedelic "After-Glow" in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities.
    Sampedro F; de la Fuente Revenga M; Valle M; Roberto N; Domínguez-Clavé E; Elices M; Luna LE; Crippa JAS; Hallak JEC; de Araujo DB; Friedlander P; Barker SA; Álvarez E; Soler J; Pascual JC; Feilding A; Riba J
    Int J Neuropsychopharmacol; 2017 Sep; 20(9):698-711. PubMed ID: 28525587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca.
    McKenna D; Riba J
    Curr Top Behav Neurosci; 2018; 36():283-311. PubMed ID: 28401525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans.
    Bouso JC; Palhano-Fontes F; Rodríguez-Fornells A; Ribeiro S; Sanches R; Crippa JA; Hallak JE; de Araujo DB; Riba J
    Eur Neuropsychopharmacol; 2015 Apr; 25(4):483-92. PubMed ID: 25637267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonergic psychedelics and personality: A systematic review of contemporary research.
    Bouso JC; Dos Santos RG; Alcázar-Córcoles MÁ; Hallak JEC
    Neurosci Biobehav Rev; 2018 Apr; 87():118-132. PubMed ID: 29452127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives.
    Pallavicini C; Vilas MG; Villarreal M; Zamberlan F; Muthukumaraswamy S; Nutt D; Carhart-Harris R; Tagliazucchi E
    Neuroimage; 2019 Oct; 200():281-291. PubMed ID: 31247301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers.
    Riba J; Anderer P; Morte A; Urbano G; Jané F; Saletu B; Barbanoj MJ
    Br J Clin Pharmacol; 2002 Jun; 53(6):613-28. PubMed ID: 12047486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shannon entropy of brain functional complex networks under the influence of the psychedelic Ayahuasca.
    Viol A; Palhano-Fontes F; Onias H; de Araujo DB; Viswanathan GM
    Sci Rep; 2017 Aug; 7(1):7388. PubMed ID: 28785066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant.
    Riba J; Romero S; Grasa E; Mena E; Carrió I; Barbanoj MJ
    Psychopharmacology (Berl); 2006 May; 186(1):93-8. PubMed ID: 16575552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanistic model of the neural entropy increase elicited by psychedelic drugs.
    Herzog R; Mediano PAM; Rosas FE; Carhart-Harris R; Perl YS; Tagliazucchi E; Cofre R
    Sci Rep; 2020 Oct; 10(1):17725. PubMed ID: 33082424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subacute effects of the psychedelic ayahuasca on the salience and default mode networks.
    Pasquini L; Palhano-Fontes F; Araujo DB
    J Psychopharmacol; 2020 Jun; 34(6):623-635. PubMed ID: 32255395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor.
    Preller KH; Burt JB; Ji JL; Schleifer CH; Adkinson BD; Stämpfli P; Seifritz E; Repovs G; Krystal JH; Murray JD; Vollenweider FX; Anticevic A
    Elife; 2018 Oct; 7():. PubMed ID: 30355445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.
    Riba J; Rodríguez-Fornells A; Barbanoj MJ
    Psychopharmacology (Berl); 2002 Dec; 165(1):18-28. PubMed ID: 12474114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications.
    Kraehenmann R
    Curr Neuropharmacol; 2017; 15(7):1032-1042. PubMed ID: 28625125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.
    Canal CE
    Handb Exp Pharmacol; 2018; 252():227-260. PubMed ID: 29532180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seeing with the eyes shut: neural basis of enhanced imagery following Ayahuasca ingestion.
    de Araujo DB; Ribeiro S; Cecchi GA; Carvalho FM; Sanchez TA; Pinto JP; de Martinis BS; Crippa JA; Hallak JE; Santos AC
    Hum Brain Mapp; 2012 Nov; 33(11):2550-60. PubMed ID: 21922603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics.
    Riba J; Valle M; Urbano G; Yritia M; Morte A; Barbanoj MJ
    J Pharmacol Exp Ther; 2003 Jul; 306(1):73-83. PubMed ID: 12660312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models of serotonergic psychedelics.
    Hanks JB; González-Maeso J
    ACS Chem Neurosci; 2013 Jan; 4(1):33-42. PubMed ID: 23336043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A whole-brain model of the neural entropy increase elicited by psychedelic drugs.
    Herzog R; Mediano PAM; Rosas FE; Lodder P; Carhart-Harris R; Perl YS; Tagliazucchi E; Cofre R
    Sci Rep; 2023 Apr; 13(1):6244. PubMed ID: 37069186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.